- Home
- WEST vs ORIC Comparison
WEST vs ORIC Comparison
Compare WEST & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEST
- ORIC
- Stock Information
- Founded
- WEST 2009
- ORIC 2014
- Country
- WEST United States
- ORIC United States
- Employees
- WEST N/A
- ORIC N/A
- Industry
- WEST Beverages (Production/Distribution)
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- WEST Consumer Staples
- ORIC Health Care
- Exchange
- WEST Nasdaq
- ORIC Nasdaq
- Market Cap
- WEST 601.4M
- ORIC 633.7M
- IPO Year
- WEST N/A
- ORIC 2020
- Fundamental
- Price
- WEST $7.35
- ORIC $9.12
- Analyst Decision
- WEST Strong Buy
- ORIC Strong Buy
- Analyst Count
- WEST 5
- ORIC 9
- Target Price
- WEST $12.20
- ORIC $18.75
- AVG Volume (30 Days)
- WEST 66.8K
- ORIC 482.7K
- Earning Date
- WEST 11-07-2024
- ORIC 11-12-2024
- Dividend Yield
- WEST N/A
- ORIC N/A
- EPS Growth
- WEST N/A
- ORIC N/A
- EPS
- WEST N/A
- ORIC N/A
- Revenue
- WEST $836,715,000.00
- ORIC N/A
- Revenue This Year
- WEST $5.15
- ORIC N/A
- Revenue Next Year
- WEST $28.78
- ORIC N/A
- P/E Ratio
- WEST N/A
- ORIC N/A
- Revenue Growth
- WEST N/A
- ORIC N/A
- 52 Week Low
- WEST $5.28
- ORIC $6.33
- 52 Week High
- WEST $11.21
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- WEST 58.52
- ORIC 46.99
- Support Level
- WEST $6.34
- ORIC $8.11
- Resistance Level
- WEST $6.97
- ORIC $8.90
- Average True Range (ATR)
- WEST 0.40
- ORIC 0.74
- MACD
- WEST 0.01
- ORIC -0.09
- Stochastic Oscillator
- WEST 77.10
- ORIC 33.78
About WEST Westrock Coffee Company
Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.